|
NIBM Update 08-18-2002 (Number 11) |
|
- Cover -
FDA sets oncology drug approval record
- Page 2 -
Genta releases Aventis partnership information
- Page 3 -
Macro Market Notes & Analysis
- Page 4 -
NIBM Model Portfolio Updates
-
(DNDN, PRXL, ALLP, IDEV, TGEN)
- Page 5 -
News Briefs
- Northfield's new CEO comes clean
- Aventis drops hypertension drug
- Forest Labs lercanidipine
delayed by FDA
- This
never happens...
|
 |
|
| NIBM Updates are
available only to subscribers. In each update we analyze current market trends inside and
outside the biotech market sector. We also provide updates on the companies that appear in
our monthly NIBM Newsletter. Click on the box above to become a
subscriber today! |
Subscriber direct access |
|
| |
|
|
 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
